Physician profile
Christopher L John
NPI 1619974599
$8,133.50
in general payments reported to CMS, 2019-2025
32 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $1,186 · 2021: $1,431 · 2022: $1,366 · 2023: $1,206 · 2024: $1,127 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,821 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,821.33 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,852.71 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,165.27 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $684.41 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $683.42 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Mylan Specialty L.P. | $490.24 | 2019-2024 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $463.34 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Philips North America LLC | $347.70 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genzyme Corporation | $322.58 | 2019-2025 | |
| United Therapeutics Corporation | $256.87 | 2019-2024 | Tyvaso, Orenitram, Remodulin |
| Regeneron Healthcare Solutions, INC. | $230.12 | 2019-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $199.04 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $198.01 | 2020-2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $127.83 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $117.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.58 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $105.94 | 2019-2021 | |
| Advanced Respiratory, INC | $101.26 | 2019-2021 | |
| Inogen, INC. | $101.24 | 2022-2023 | Inogen At Home Stationary Concentrator |
| Merck Sharp & Dohme LLC | $96.18 | 2023-2025 | Winrevair |
| Electromed, INC. | $93.83 | 2019-2025 | Smartvest |
| Pulmonx Corporation | $65.42 | 2023-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Baxter Healthcare | $54.57 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $46.35 | 2019-2021 | |
| Circassia INC. | $41.87 | 2019 | |
| Paratek Pharmaceuticals, INC. | $34.42 | 2023 | Nuzyra |
| Shire North American Group INC | $29.71 | 2019 | |
| 3b Medical, INC. | $23.77 | 2025 | Luna |
| Insmed, INC. | $23.51 | 2025 | Arikayce |
| Verona Pharma, INC. | $19.80 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $17.52 | 2021 | |
| Viatris Specialty LLC | $16.89 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $6.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.